label evaluation of the efficacy, safety, and tolerability of ExQW(intended commercial material) compared with ExBID. Patientswere randomized 1:1 to treatment with ExBID or ExQW, withrandomization performed centrally via an interactive voice or1302 Blevins et al. Better Glycemic Control with Exenatide Once Weekly J Clin Endocrinol Metab, May 2011, 96(5):1301â€“1310 The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 13 May 2015. at 07:22 For personal use only. No other uses without permission. . All rights reserved.